OrbusNeich Medical Group Holdings Limited (6929.HK)

HKD 4.08

(-0.97%)

Market Cap (In HKD)

3.36 Billion

Revenue (In HKD)

153.86 Million

Net Income (In HKD)

45.07 Million

Avg. Volume

105.16 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.86-7.06
PE
-
EPS
-
Beta Value
0.0
ISIN
KYG6773B1005
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. David Chien
Employee Count
-
Website
https://orbusneich.com
Ipo Date
2022-12-23
Details
OrbusNeich Medical Group Holdings Limited, an investment holding company, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Shatin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.